Stockreport

Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update

Roivant Sciences Ltd.  (ROIV) 
PDF Early launch data for VTAMA® (tapinarof) with approximately 14,000 prescriptions written by more than 3,000 unique prescribers in initial eleven weeks of launch shows st [Read more]